ImmunoGen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
ImmunoGen, Inc. (ImmunoGen or ‘the company’) is a developer of targeted anticancer therapeutics using its antibody-drug conjugate (ADC) technology. The ADC technology is comprised of the company's portfolio of cancer-cell killing agents that can be attached to antibodies for targeted delivery to cancer cells. The major partners of the company include Roche, Huadong, CytomX, Debiopharm, Bayer, Novartis, Oxford BioTherapeutics/Menarini, Fusion and Viridian use the company's ADC technology to develop anticancer therapies. ImmunoGen is headquartered in Waltham, Massachusetts, the US.Scope
- Detailed information on ImmunoGen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting ImmunoGen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of ImmunoGen, Inc. including a breakdown and examination of key business segments
- Intelligence on ImmunoGen, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about ImmunoGen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of ImmunoGen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess ImmunoGen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on ImmunoGen, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- ImmunoGen, Inc.: Company Overview
- ImmunoGen, Inc.: Overview and Key Facts
- ImmunoGen, Inc.: Overview
- ImmunoGen, Inc.: Key Facts
- ImmunoGen, Inc.: Key Employees
- ImmunoGen, Inc.: Key Employee Biographies
- ImmunoGen, Inc.: Major Products and Services
- ImmunoGen, Inc.: Management Statement
- ImmunoGen, Inc.: Key Competitors
- ImmunoGen, Inc.: Company Analysis
- ImmunoGen, Inc.: Business Description
- ImmunoGen, Inc.: SWOT Analysis
- ImmunoGen, Inc.: SWOT Overview
- ImmunoGen, Inc.: Strengths
- ImmunoGen, Inc.: Weaknesses
- ImmunoGen, Inc.: Opportunities
- ImmunoGen, Inc.: Threats
- ImmunoGen, Inc.: Corporate Financial Deals Activity
- ImmunoGen, Inc.: Financial Deals Overview
- ImmunoGen, Inc.: Targets and Partners
- ImmunoGen, Inc.: Top Deals 2019 - 2023YTD*
- ImmunoGen, Inc.: Advisors
- ImmunoGen, Inc.: Top Legal Advisors
- ImmunoGen, Inc.: Top Financial Advisors
- ImmunoGen, Inc.: Capital Raising
- ImmunoGen, Inc.: Partnership
- ImmunoGen, Inc.: Recent Developments
- ImmunoGen, Inc.: News and Events Summary
- ImmunoGen, Inc.: Contracts
- ImmunoGen, Inc.: Corporate Governance
- ImmunoGen, Inc.: Financial Deals
- ImmunoGen, Inc.: Financial Performance
- ImmunoGen, Inc.: Grants
- ImmunoGen, Inc.: Market Developments
- ImmunoGen, Inc.: Regulatory and Legal Events
- ImmunoGen, Inc.: Research & Development
- Appendix
- Contact Us
- Methodology
Table 1: ImmunoGen, Inc.: Key Facts
Table 2: ImmunoGen, Inc.: Key Employees
Table 3: ImmunoGen, Inc.: Key Competitors
Table 4: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 6: ImmunoGen, Inc.: Targets and Partners
Table 7: ImmunoGen, Inc.: Top Deals 2019 - 2023YTD*
Table 8: ImmunoGen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 9: ImmunoGen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: ImmunoGen, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 11: ImmunoGen, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 12: ImmunoGen, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 13: ImmunoGen, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 14: ImmunoGen, Inc.: News and Events Summary
Table 15: ImmunoGen, Inc.: Contracts
Table 16: ImmunoGen, Inc.: Corporate Governance
Table 17: ImmunoGen, Inc.: Financial Deals
Table 18: ImmunoGen, Inc.: Financial Performance
Table 19: ImmunoGen, Inc.: Grants
Table 20: ImmunoGen, Inc.: Market Developments
Table 21: ImmunoGen, Inc.: Regulatory and Legal Events
Table 22: ImmunoGen, Inc.: Research & Development
List of Figures
Figure 1: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: ImmunoGen, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 4: ImmunoGen, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 5: ImmunoGen, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 6: ImmunoGen, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
